Global HPV Testing Market Analysis and Forecast 2024-2030

Global HPV Testing Market Analysis and Forecast 2024-2030


Summary

The human papillomavirus (HPV) test detects the presence of human papillomavirus, a virus that can lead to the development of genital warts, abnormal cervical cells or cervical cancer. The HPV testing is further classified into three sub-segments, namely, follow-up testing, co-testing, HPV primary testing.

According to APO Research, The global HPV Testing market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for HPV Testing is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for HPV Testing is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for HPV Testing is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for HPV Testing is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global companies of HPV Testing include Qiagen, Roche Diagnostics, Hologic, Abbott Laboratories, BD and Seegene, Inc., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Includes

This report presents an overview of global market for HPV Testing, market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of HPV Testing, also provides the revenue of main regions and countries. Of the upcoming market potential for HPV Testing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the HPV Testing revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global HPV Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for HPV Testing revenue, projected growth trends, production technology, application and end-user industry.

HPV Testing segment by Company

Qiagen
Roche Diagnostics
Hologic
Abbott Laboratories
BD
Seegene, Inc.
HPV Testing segment by Type

HPV Testing
Follow-up HPV Testing
Co-testing
HPV Testing segment by Application

Cervical Cancer Screening
Vaginal Cancer Screening
Other
HPV Testing segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global HPV Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of HPV Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of HPV Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of HPV Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of HPV Testing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, HPV Testing revenue, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.


1 Market Overview
1.1 Product Definition
1.2 HPV Testing Market by Type
1.2.1 Global HPV Testing Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 HPV Testing
1.2.3 Follow-up HPV Testing
1.2.4 Co-testing
1.3 HPV Testing Market by Application
1.3.1 Global HPV Testing Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Cervical Cancer Screening
1.3.3 Vaginal Cancer Screening
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 HPV Testing Market Dynamics
2.1 HPV Testing Industry Trends
2.2 HPV Testing Industry Drivers
2.3 HPV Testing Industry Opportunities and Challenges
2.4 HPV Testing Industry Restraints
3 Global Growth Perspective
3.1 Global HPV Testing Market Perspective (2019-2030)
3.2 Global HPV Testing Growth Trends by Region
3.2.1 Global HPV Testing Market Size by Region: 2019 VS 2023 VS 2030
3.2.2 Global HPV Testing Market Size by Region (2019-2024)
3.2.3 Global HPV Testing Market Size by Region (2025-2030)
4 Competitive Landscape by Players
4.1 Global HPV Testing Revenue by Players
4.1.1 Global HPV Testing Revenue by Players (2019-2024)
4.1.2 Global HPV Testing Revenue Market Share by Players (2019-2024)
4.1.3 Global HPV Testing Players Revenue Share Top 10 and Top 5 in 2023
4.2 Global HPV Testing Key Players Ranking, 2022 VS 2023 VS 2024
4.3 Global HPV Testing Key Players Headquarters & Area Served
4.4 Global HPV Testing Players, Product Type & Application
4.5 Global HPV Testing Players Commercialization Time
4.6 Market Competitive Analysis
4.6.1 Global HPV Testing Market CR5 and HHI
4.6.2 Global Top 5 and 10 HPV Testing Players Market Share by Revenue in 2023
4.6.3 2023 HPV Testing Tier 1, Tier 2, and Tier 3
5 HPV Testing Market Size by Type
5.1 Global HPV Testing Revenue by Type (2019 VS 2023 VS 2030)
5.2 Global HPV Testing Revenue by Type (2019-2030)
5.3 Global HPV Testing Revenue Market Share by Type (2019-2030)
6 HPV Testing Market Size by Application
6.1 Global HPV Testing Revenue by Application (2019 VS 2023 VS 2030)
6.2 Global HPV Testing Revenue by Application (2019-2030)
6.3 Global HPV Testing Revenue Market Share by Application (2019-2030)
7 Company Profiles
7.1 Qiagen
7.1.1 Qiagen Comapny Information
7.1.2 Qiagen Business Overview
7.1.3 Qiagen HPV Testing Revenue and Gross Margin (2019-2024)
7.1.4 Qiagen HPV Testing Product Portfolio
7.1.5 Qiagen Recent Developments
7.2 Roche Diagnostics
7.2.1 Roche Diagnostics Comapny Information
7.2.2 Roche Diagnostics Business Overview
7.2.3 Roche Diagnostics HPV Testing Revenue and Gross Margin (2019-2024)
7.2.4 Roche Diagnostics HPV Testing Product Portfolio
7.2.5 Roche Diagnostics Recent Developments
7.3 Hologic
7.3.1 Hologic Comapny Information
7.3.2 Hologic Business Overview
7.3.3 Hologic HPV Testing Revenue and Gross Margin (2019-2024)
7.3.4 Hologic HPV Testing Product Portfolio
7.3.5 Hologic Recent Developments
7.4 Abbott Laboratories
7.4.1 Abbott Laboratories Comapny Information
7.4.2 Abbott Laboratories Business Overview
7.4.3 Abbott Laboratories HPV Testing Revenue and Gross Margin (2019-2024)
7.4.4 Abbott Laboratories HPV Testing Product Portfolio
7.4.5 Abbott Laboratories Recent Developments
7.5 BD
7.5.1 BD Comapny Information
7.5.2 BD Business Overview
7.5.3 BD HPV Testing Revenue and Gross Margin (2019-2024)
7.5.4 BD HPV Testing Product Portfolio
7.5.5 BD Recent Developments
7.6 Seegene, Inc.
7.6.1 Seegene, Inc. Comapny Information
7.6.2 Seegene, Inc. Business Overview
7.6.3 Seegene, Inc. HPV Testing Revenue and Gross Margin (2019-2024)
7.6.4 Seegene, Inc. HPV Testing Product Portfolio
7.6.5 Seegene, Inc. Recent Developments
8 North America
8.1 North America HPV Testing Revenue (2019-2030)
8.2 North America HPV Testing Revenue by Type (2019-2030)
8.2.1 North America HPV Testing Revenue by Type (2019-2024)
8.2.2 North America HPV Testing Revenue by Type (2025-2030)
8.3 North America HPV Testing Revenue Share by Type (2019-2030)
8.4 North America HPV Testing Revenue by Application (2019-2030)
8.4.1 North America HPV Testing Revenue by Application (2019-2024)
8.4.2 North America HPV Testing Revenue by Application (2025-2030)
8.5 North America HPV Testing Revenue Share by Application (2019-2030)
8.6 North America HPV Testing Revenue by Country
8.6.1 North America HPV Testing Revenue by Country (2019 VS 2023 VS 2030)
8.6.2 North America HPV Testing Revenue by Country (2019-2024)
8.6.3 North America HPV Testing Revenue by Country (2025-2030)
8.6.4 U.S.
8.6.5 Canada
9 Europe
9.1 Europe HPV Testing Revenue (2019-2030)
9.2 Europe HPV Testing Revenue by Type (2019-2030)
9.2.1 Europe HPV Testing Revenue by Type (2019-2024)
9.2.2 Europe HPV Testing Revenue by Type (2025-2030)
9.3 Europe HPV Testing Revenue Share by Type (2019-2030)
9.4 Europe HPV Testing Revenue by Application (2019-2030)
9.4.1 Europe HPV Testing Revenue by Application (2019-2024)
9.4.2 Europe HPV Testing Revenue by Application (2025-2030)
9.5 Europe HPV Testing Revenue Share by Application (2019-2030)
9.6 Europe HPV Testing Revenue by Country
9.6.1 Europe HPV Testing Revenue by Country (2019 VS 2023 VS 2030)
9.6.2 Europe HPV Testing Revenue by Country (2019-2024)
9.6.3 Europe HPV Testing Revenue by Country (2025-2030)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
10 China
10.1 China HPV Testing Revenue (2019-2030)
10.2 China HPV Testing Revenue by Type (2019-2030)
10.2.1 China HPV Testing Revenue by Type (2019-2024)
10.2.2 China HPV Testing Revenue by Type (2025-2030)
10.3 China HPV Testing Revenue Share by Type (2019-2030)
10.4 China HPV Testing Revenue by Application (2019-2030)
10.4.1 China HPV Testing Revenue by Application (2019-2024)
10.4.2 China HPV Testing Revenue by Application (2025-2030)
10.5 China HPV Testing Revenue Share by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia HPV Testing Revenue (2019-2030)
11.2 Asia HPV Testing Revenue by Type (2019-2030)
11.2.1 Asia HPV Testing Revenue by Type (2019-2024)
11.2.2 Asia HPV Testing Revenue by Type (2025-2030)
11.3 Asia HPV Testing Revenue Share by Type (2019-2030)
11.4 Asia HPV Testing Revenue by Application (2019-2030)
11.4.1 Asia HPV Testing Revenue by Application (2019-2024)
11.4.2 Asia HPV Testing Revenue by Application (2025-2030)
11.5 Asia HPV Testing Revenue Share by Application (2019-2030)
11.6 Asia HPV Testing Revenue by Country
11.6.1 Asia HPV Testing Revenue by Country (2019 VS 2023 VS 2030)
11.6.2 Asia HPV Testing Revenue by Country (2019-2024)
11.6.3 Asia HPV Testing Revenue by Country (2025-2030)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 China Taiwan
11.6.9 Southeast Asia
12 Middle East, Africa, Latin America
12.1 MEALA HPV Testing Revenue (2019-2030)
12.2 MEALA HPV Testing Revenue by Type (2019-2030)
12.2.1 MEALA HPV Testing Revenue by Type (2019-2024)
12.2.2 MEALA HPV Testing Revenue by Type (2025-2030)
12.3 MEALA HPV Testing Revenue Share by Type (2019-2030)
12.4 MEALA HPV Testing Revenue by Application (2019-2030)
12.4.1 MEALA HPV Testing Revenue by Application (2019-2024)
12.4.2 MEALA HPV Testing Revenue by Application (2025-2030)
12.5 MEALA HPV Testing Revenue Share by Application (2019-2030)
12.6 MEALA HPV Testing Revenue by Country
12.6.1 MEALA HPV Testing Revenue by Country (2019 VS 2023 VS 2030)
12.6.2 MEALA HPV Testing Revenue by Country (2019-2024)
12.6.3 MEALA HPV Testing Revenue by Country (2025-2030)
12.6.4 Mexico
12.6.5 Brazil
12.6.6 Israel
12.6.7 Argentina
12.6.8 Colombia
12.6.9 Turkey
12.6.10 Saudi Arabia
12.6.11 UAE
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings